Intrinsiqs

Is Arcutis Biotherapeutics, Inc. overvalued?

Arcutis Biotherapeutics, Inc. (ARQT) — key valuation metrics and fundamentals.

No verdict
Price
$28.26
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$3.57B
Dividend yield
0.0%
Return on equity
14.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ARQT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.